NCT02112552 Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Status TERMINATED Phase PHASE2
NCT02106988 Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02106546 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02102438 Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer Status WITHDRAWN Phase NA
NCT02087241 Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer Status TERMINATED Phase PHASE2
NCT02073968 PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02071537 Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02069158 Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT02065687 Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT02059967 Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC Status WITHDRAWN Phase PHASE1
NCT02051868 International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel Status UNKNOWN Phase PHASE2
NCT02050009 Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status WITHDRAWN Phase PHASE1
NCT02048020 Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer Status COMPLETED Phase PHASE2
NCT02046421 Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT02044601 Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02041533 An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Status COMPLETED Phase PHASE3
NCT02039791 Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer Status UNKNOWN Phase PHASE2
NCT02039674 A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) Status COMPLETED Phase PHASE1/PHASE2
NCT02037048 FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2